| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |